ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    ASP0113 Elicits an Immune Response in CMV-Seronegative Dialysis Patients: Comparison to Healthy Subjects.

    P. Bonate,1 C. Van Sant,2 K. Cho,1 E. Zook,1 L. Smith,3 S. Boutsaboualoy, X. Wang,1 R. Wu,1 A. Koester,4 D. Rammelsberg,6 R. Goldwater,4 T. Marbury.5

    1Astellas Pharma Global Development, Northbrook; 2Astellas Research Institute of America, Skokie; 3Vical Inc, San Diego; 4PAREXEL International, Baltimore; 5Orlando Clinical Research Center, Orlando; 6Randstad Pharma, Deerfield, IL, United States (on assignment at Astellas Pharma Global Development, Northbrook, United States)

    Introduction: ASP0113 is a first-in-class, DNA-based vaccine in development for the prevention of CMV infection in at-risk hematopoietic cell transplant.Methods: A Phase 1, single-blind, parallel-group,…
  • 2017 American Transplant Congress

    The Impact of Hepatitis C Treatment on GFR and Immunosuppression in Renal Transplant Recipients.

    J. Husson, R. Adekunle, B. Ravichandran, P. Mathur, S. Jonchhe, K. Stafford.

    University of Maryland Medical Center, Baltimore, MD

    Background: Renal transplant recipients (RTRs) with HCV are at an increased risk of graft rejection, making treatment of HCV in this population of the utmost…
  • 2017 American Transplant Congress

    Usefulness of Valacyclovir Prophylaxis for Preventing Cytomegalovirus Infection After Anti-Thymocyte Globulin Treatment as Antirejection Therapy.

    E. Ko,1,2 J. Yu,1,2 B. Choi,1,2 C. Park,1,2 Y. Kim,1,2 C. Yang,1,2 B. Chung.1,2

    1Transplant Research Center, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea; 2Division of Nephrology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea

    Anti-thymocyte globulin (ATG) treatment for acute T-cell mediated rejection (TCMR) can increase the risk of CMV infection. We purposed to evaluate the effect of valacyclovir…
  • 2017 American Transplant Congress

    BKV Clearance Time Correlates with T-Cell Receptor Repertoire Shape and Exhaustion State of BKV-Specific T-Cells in Renal Transplant Patients with Severe BKV Infection.

    U. Stervbo,1,2 M. Nienen,1 B. Weist,2 P. Wehler,2 T. Westhoff,1 H.-D. Volk,2 P. Reinke,2 N. Babel.1,2

    1Center for Translational Medicine, Medical Clinic I, Marienhospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies, Charité – University Medicine, Berlin, Germany

    Reactivation of the BK polyomavirus is known to lead to severe complications in kidney transplant patients. The current treatment strategy relies on decreasing the immunosuppression…
  • 2017 American Transplant Congress

    Fate and Function of CD8+ T Cells Primed by Fetal Antigen During Pregnancy.

    P. Porrett,1 R. Xu,1 E. Wherry.2

    1Surgery, University of Pennyslvania, Philadelphia, PA; 2Microbiology, University of Pennsylvania, Philadelphia, PA

    Background The long-term fate of maternal T cells primed by fetal antigen during pregnancy has not been well studied but may have significant impact for…
  • 2017 American Transplant Congress

    Quantity and Functions of CD4–CD8– Double Negative (DN) αβ T Cells in Kidney Is MHC Dependent.

    M. Sadasivam, S. Noel, S. Lee, A. Hamad, H. Rabb.

    Johns Hopkins University, Baltimore, MD

    Background: Prior studies have established important roles of CD4+ T cells, natural killer T cells, and CD4+CD25+FoxP3+ Tregs in kidney ischemia reperfusion injury (IRI) pathogenesis.…
  • 2017 American Transplant Congress

    Low Level Early Onset De Novo DSA's May Not Portend Early Graft Dysfunction in Kidney Transplant Recipients.

    M. Abate, Y. Nigatu, B. Ryu, F. Darras, R. Jafrin, H. Suh, C. Estrada, E. Nord.

    Nephrology and Hypertension, Stony Brook Medicine, Stony Brook, NY

    Background: The occurrence of anti-HLA de novo DSA (dnDSA) has been associated with the histological features of antibody-mediated rejection (ABMR) on kidney biopsy. The significance…
  • 2017 American Transplant Congress

    Non-Donor-Specific Anti-HLA Antibodies Have an Adverse Impact in Kidney Graft Outcomes.

    J. Malheiro,1 S. Tafulo,2 L. Dias,1 L. Martins,1 I. Beirão,1 A. Castro-Henriques.1

    1CHP, Porto, Portugal; 2IPST, Porto, Portugal

    Few studies have studied the impact of non-donor-specific antibodies (NDSA) in kidney transplantation (KT), with most showing no impact of these antibodies. As antibody-mediated graft…
  • 2017 American Transplant Congress

    Clinical Experience with Novel Cephalosporin/Beta-Lactamase Inhibitor Combinations in the Treatment of Multidrug Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplant Recipients.

    P. Nambiar,1 K. Brizendine,1 V. Athans,2 E. Cober.1

    1Infectious Disease, Cleveland Clinic Foundation, Cleveland; 2Pharmacy, Cleveland Clinic Foundation, Cleveland

    Purpose: To review clinical outcomes in organ transplant recipients (OTRs) treated with Ceftazidime/avibactam (C/A) and ceftolozane/tazobactam (C/T) for infections caused by Multidrug resistant Pseudomonas aeruginosa…
  • 2017 American Transplant Congress

    The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation.

    R. Klasek,1 S. Kuten,1 S. Patel,1,3 D. Nguyen,1 E. Graviss,1 A. Gaber,1 R. Knight.1

    1Houston Methodist Hospital, Houston, TX; 2Veloxis Pharmaceuticals, Cary, NC

    Previous studies have shown that approximately 20% of febrile episodes in transplant recipients are not associated with infection. At our center, fever of unknown origin…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences